Time-Restricted Eating to Address Persistent Cancer-Related Fatigue
2 other identifiers
interventional
50
1 country
1
Brief Summary
This study will assess the feasibility of delivering a 12-week time-restricted eating intervention as well as the intervention's preliminary efficacy on persistent cancer-related fatigue among cancer survivors compared to a general health education control. Participants will be randomized 1:1 to one of two arms: time-restricted eating or control. Those in the intervention arm will self-select a 10-hour eating window in which to consume all food and beverages (water is allowed any time, black coffee and unsweetened tea are allowed in the morning). Both groups will receive weekly educational tips on healthy lifestyle behaviors in cancer survivorship. This study will also explore relationships between fatigue, circadian rhythm, and glucose metabolism. The hypothesis is that recruitment will be feasible, and participants will adhere to time-restricted eating and complete study activities over the course of the 12 weeks. The second hypothesis is that time-restricted eating will lead to less fatigue at 12 weeks compared to the control, accounting for baseline fatigue levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2022
CompletedFirst Posted
Study publicly available on registry
February 25, 2022
CompletedStudy Start
First participant enrolled
January 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedResults Posted
Study results publicly available
May 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMay 7, 2025
May 1, 2025
1.3 years
February 16, 2022
April 17, 2025
May 6, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility, as Assessed by the Percentage of Participants Who Enrolled Completed the Study
To assess feasibility, the percentage of participants who provide evaluable data regarding their eating window at baseline and 12 weeks will be assessed.
12 weeks
Fatigue, as Assessed Using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Questionnaire
FACIT-F fatigue subscale scores will be compared for those in the time-restricted eating group vs. the control group at week 12, controlling for baseline levels. This questionnaire is 13-items long. The scale is from 0-52, and a higher score indicates less fatigue.
12 weeks
Study Arms (2)
Time-restricted eating
EXPERIMENTALParticipants will self-select a 10-hour window in which to consume all food and beverages (with the exception of black coffee and unsweetened tea in the mornings; water is okay at all times). Participants will also receive weekly tips to encourage a healthy lifestyle in cancer survivorship.
Control
OTHERParticipants will receive weekly tips to encourage healthy lifestyle behaviors in cancer survivorship.
Interventions
12 weeks of time-restricted eating (10-hour window)
Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks
Eligibility Criteria
You may qualify if:
- Have completed adjuvant chemotherapy, surgery, and/or radiation for cancer, including chemotherapy for hematologic neoplasms, at least 2 months and not more than 2 years prior to enrolling,
- Have a baseline level of fatigue, as determined by reporting a score of 4 or higher for the question, "In the last week, how bad was your worst fatigue on a scale from 0-10?"
- Be able to speak and/or read and write in English,
- Be at least 18 years old,
- Own a smartphone,
- Be willing and able to adhere to study procedures, including use of a smartphone app, and
- Be able to provide informed consent.
You may not qualify if:
- Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week,
- Be underweight, as defined as a body mass index ≤18.5 kg/m2,
- Have surgery planned during the study duration,
- Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., type 1 diabetes, risk for hypoglycemia, medication requirements, pregnancy, breastfeeding, recent history of an eating disorder),
- Be taking insulin, or
- Be on enteral or parenteral nutrition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Maryland, Baltimore
Baltimore, Maryland, 21201, United States
Related Publications (1)
Kleckner AS, Clingan CL, Youngblood SM, Kleckner IR, Quick L, Elrod RD, Zhu S, Manoogian ENC, Panda S, Badros AZ, Emadi A. Time-restricted eating to address persistent cancer-related fatigue among cancer survivors: a randomized controlled trial. Support Care Cancer. 2025 Apr 5;33(4):353. doi: 10.1007/s00520-025-09394-w.
PMID: 40186671DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Amber Kleckner, PhD
- Organization
- University of Maryland School of Nursing
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 16, 2022
First Posted
February 25, 2022
Study Start
January 26, 2023
Primary Completion
June 1, 2024
Study Completion
April 1, 2026
Last Updated
May 7, 2025
Results First Posted
May 7, 2025
Record last verified: 2025-05